Cutler Group LP Immunity Bio, Inc. Call Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	SELL	$1.29 - $3.1 $2,193 - $5,270	-1,700 Reduced 77.27%	500 $0
Q2 2023 Jul 18, 2023	BUY	$1.53 - $6.41 $1,989 - $8,333	1,300 Added 144.44%	2,200 $0
Q1 2023 May 01, 2023	SELL	$1.35 - $4.78 $10,665 - $37,762	-7,900 Reduced 89.77%	900 $0
Q4 2022 Feb 07, 2023	SELL	$4.35 - $6.77 $9,570 - $14,893	-2,200 Reduced 20.0%	8,800 $1,000
Q3 2022 Oct 25, 2022	BUY	$3.65 - $6.43 $13,870 - $24,434	3,800 Added 52.78%	11,000 $4,000
Q2 2022 Aug 04, 2022	BUY	$2.68 - $6.14 $5,360 - $12,280	2,000 Added 38.46%	7,200 $1,000
Q1 2022 Apr 14, 2022	BUY	$5.05 - $7.53 $24,240 - $36,144	4,800 Added 1200.0%	5,200 $0
Q4 2021 Jan 18, 2022	SELL	$5.67 - $10.18 $2,835 - $5,090	-500 Reduced 55.56%	400 $0
Q3 2021 Oct 26, 2021	SELL	$9.17 - $14.24 $1,834 - $2,848	-200 Reduced 18.18%	900 $0
Q2 2021 Jul 19, 2021	SELL	$13.41 - $22.4 $100,575 - $168,000	-7,500 Reduced 87.21%	1,100 $0
Q1 2021 Apr 26, 2021	BUY	$12.83 - $42.25 $110,338 - $363,350	8,600 New	8,600 $15,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.03B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.